Disease-modifying factors in hereditary angioedema: An RNA expression-based screening

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  López Lera, Alberto ^a,b   Cabo, Fátima Sánchez ^c   Garrido, Sofía ^a   Dopazo, Ana ^c   López Trascasa, Margarita ^a,b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Disease modifying factor; Expression microarray; Hereditary angioedema; Infection

Indexed keywords

RNA;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FOLDING; UNINDEXED SEQUENCE;

COMPLEMENT C1 INHIBITOR PROTEIN; FAMILY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HEREDITARY ANGIOEDEMA TYPES I AND II; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEDIGREE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 84877854640     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-77     Document Type: Article

References (27)

1. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. Caballero T, Baeza ML, Cabañas R, Campos A, Cimbollek S, Gómez-Traseira C, González-Quevedo T, Guilarte M, Jurado-Palomo J, Larco JI, López-Serrano MC, López-Trascasa M, Marcos C, Muñoz-Caro JM, Pedrosa M, Prior N, Rubio M, Sala-Cunill A, Spanish Study Group on Bradykinin-Induced Angioedema (SGBA), J Investig Allergol Clin Immunol 2011 21 5 333 347 21905496
2. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Cichon S, Martin L, Hennies HC, Müller F, Van Driessche K, Karpushova A, Stevens W, Colombo R, Renné T, Drouet C, Bork K, Nöthen MM, Am J Hum Genet 2006 79 6 1098 1104 10.1086/509899 17186468 (Pubitemid 44853481)
3. Cross-talk between the complement and the kinin system in vascular permeability. Bossi F, Peerschke EI, Ghebrehiwet B, Tedesco F, Immunol Lett 2011 140 1-2 7 13 21762728
4. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Joseph K, Tuscano TB, Kaplan AP, Ann Allergy Asthma Immunol 2008 101 3 279 286 10.1016/S1081-1206(10)60493-0 18814451
5. Plasma bradykinin in angio-oedema. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A, Lancet 1998 351 9117 1693 1697 10.1016/S0140-6736(97)09137-X 9734886 (Pubitemid 28254530)
6. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, Fekete B, Fischer B, Fontana L, Füst G, Giacomelli R, Gröner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmár L, Kaposi PN, Karádi I, Kitzinger A, Kollár T, Kreuz W, Lakatos P, Longhurst HJ, Lopez-Trascasa M, Martinez-Saguer I, Monnier N, Nagy I, Németh E, Nielsen EW, Nuijens JH, O'grady C, Pappalardo E, Penna V, Perricone C, Perricone R, Rauch U, Roche O, Rusicke E, Späth PJ, Szendei G, Takács E, Tordai A, Truedsson L, Varga L, Visy B, Williams K, Zanichelli A, Zingale L, J Allergy Clin Immunol 2004 114 3 Suppl 51 S131 15356535
7. Modification of peripheral blood T-lymphocyte surface receptors and Langerhans cell numbers in hereditary angioedema. Cillari E, Misiano G, Aricò M, La Rocca E, Lio D, di Leonardo S, Brai M, Am J Clin Pathol 1986 85 3 305 311 2944374 (Pubitemid 16071216)
8. Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities. Brickman CM, Tsokos GC, Chused TM, Balow JE, Lawley TJ, Santaella M, Hammer CH, Linton GF, Frank MM, J Allergy Clin Immunol 1986 77 5 758 767 10.1016/0091-6749(86)90425-2 3486201
9. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. Gelfand JA, Sherins RJ, Alling DW, Frank MM, N Engl J Med 1976 295 26 1444 1448 10.1056/NEJM197612232952602 792688 (Pubitemid 8003704)
10. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bolstad BM, Irizarry RA, Astrand M, Speed TP, Bioinformatics 2003 19 2 185 193 10.1093/bioinformatics/19.2.185 12538238 (Pubitemid 36181903)
11. ACE inhibitor-induced angioedema. Vasekar M, Craig TJ, Curr Allergy Asthma Rep 2012 12 1 72 78 10.1007/s11882-011-0238-z 22127615
12. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reise Sousa C, Matsuura Y, Fujita T, Akira S, Nature 2006 441 7089 101 105 10.1038/nature04734 16625202
13. Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5. Co JG, Witwer KW, Gama L, Zink MC, Clements JE, J Infect Dis 2011 204 7 1104 1114 10.1093/infdis/jir469 21881126
14. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Greenfeder S, Umland SP, Cuss FM, Chapman RW, Egan RW, Respir Res 2001 2 2 71 79 Review 10.1186/rr41 11686868 (Pubitemid 34187910)
15. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Mukaida N, Am J Physiol Lung Cell Mol Physiol 2003 284 4 566 L577 Review 12618418
16. The evolution of Olig genes and their roles in myelination. Li H, Richardson WD, Neuron Glia Biol 2008 4 2 129 135 10.1017/S1740925X09990251 19737433
17. Regulation of alternative splicing by PTB and associated factors. Spellman R, Rideau A, Matlin A, Gooding C, Robinson F, McGlincy N, Grellscheid SN, Southby J, Wollerton M, Smith CW, Biochem Soc Trans 2005 33 Pt 3 457 460 15916540 (Pubitemid 40873864)
18. No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene. Freiberger T, Grombiříková H, Ravčuková B, Jarkovský J, Kuklínek P, Kryštůfková O, Hanzlí ková J, Daňková E, Kopecký O, Zachová R, Lahodná M, Vašáková M, Grodecká L, Litzman J, Scand J Immunol 2011 74 1 100 106 10.1111/j.1365-3083.2011.02547.x 21375555
19. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Duan QL, Nikpoor B, Dube MP, Molinaro G, Meijer IA, Dion P, Rochefort D, Saint-Onge J, Flury L, Brown NJ, Gainer JV, Rouleau JL, Agostoni A, Cugno M, Simon P, Clavel P, Potier J, Wehbe B, Benarbia S, Marc-Aurele J, Chanard J, Foroud T, Adam A, Rouleau GA, Am J Hum Genet 2005 77 4 617 626 10.1086/496899 16175507 (Pubitemid 41361608)
20. Successful allogeneic cord blood transplantation in a patient with Evans syndrome leads to correction of hereditary angioedema type I as secondary effect. Klausegger A, Wiednig M, Urban C, Lackner H, Reiter H, Bauer JW, Aberer W, Bone Marrow Transplant 2012 47 9 1259 1261 10.1038/bmt.2012.7 22327128
21. Immunoregulatory disorders associated with hereditary angioedema. I. Clinical manifestations of autoimmune disease. Brickman CM, Tsokos GC, Balow JE, Lawley TJ, Santaella M, Hammer CH, Frank MM, J Allergy Clin Immunol 1986 77 5 749 757 10.1016/0091-6749(86)90424-0 3084606 (Pubitemid 16117313)
22. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency. Farkas H, Csuka D, Gács J, Czaller I, Zotter Z, Füst G, Varga L, Gergely P, Clin Immunol 2011 141 1 58 66 Epub 2011 10.1016/j.clim.2011.05.004 21636327
23. The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency. Kessel A, Peri R, Perricone R, Guarino MD, Vadasz Z, Novak R, Haj T, Kivity S, Toubi E, Clin Exp Immunol 2012 167 3 422 428 10.1111/j.1365-2249.2011.04527.x 22288585
24. Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults. Cedzyński M, Madaliński K, Gregorek H, Swierzko AS, Nowicka E, Obtułowicz K, Dzierzanowska-Fangrat K, Wojda U, Rabczenko D, Kawakami M, Arch Immunol Ther Exp (Warsz) 2008 56 1 69 75 10.1007/s00005-008-0004-7
25. Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Farkas H, Gyeney L, Majthényi P, Füst G, Varga L, Z Gastroenterol 1999 37 6 513 518 10427658 (Pubitemid 29462683)
26. Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Farkas H, Füst G, Fekete B, Karádi I, Varga L, Lancet 2001 358 9294 1695 1696 10.1016/S0140-6736(01)06720-4 11728547 (Pubitemid 33124330)
27. Hereditary angioedema: the clinical syndrome and its management. Frank MM, Gelfand JA, Atkinson JP, Ann Intern Med 1976 84 5 580 593 10.7326/0003-4819-84-5-580 1275365